As it has been shown that extracellular lipids play an important role in promoting breast cancer growth and progression30, these results suggest that the changes in metabolic profiles caused by ADAMTSL1 genetic variants may also influence the prognosis of breast cancer after treatment. The gene discussed is ADAMTSL1; the disease is breast carcinoma.